This contract supports the advanced development of candidate products, comprised of a vaccine component and a delivery technology, for use in post-event settings following the intentional release of a biothreat agent or naturally occurring outbreaks of infectious diseases. Such biodefense vaccine technologies are intended to simplify and expedite delivery of vaccine to large numbers of patients.

Agency
National Institute of Health (NIH)
Type
Research and Development Contracts (N01)
Project #
272201000035C-9-0-1
Application #
8844784
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2014
Total Cost
Indirect Cost